Misonix Announces New Distribution Agreement for France
FARMINGDALE, N.Y., Sept. 8 /PRNewswire/ -- Misonix, Inc. (Nasdaq: MSON), a developer of state of the art, ultrasonic medical device technology, which worldwide is used for acute health conditions, has entered into a new, three year, exclusive distribution agreement with Cormedica s.a.s. Based near Lyon, France, Cormedica will distribute the BoneScalpel™ Ultrasonic Bone Cutter. The agreement provides Cormedica with the rights to sell throughout France, and includes annual minimum purchase requirements.
Cormedica has a lengthy record of successful new product introductions and long history as a distributor of high tech medical devices and capital equipment, with special emphasis on Neuro, Spine, and Maxillo-facial Surgery.
The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures. It offers the convenience and speed of a power instrument without the safety issues often associated with rotary sharps.
"Misonix is pleased to add Cormedica to our growing family of specialty distributors. Their reputation as a successful distributor of medical equipment in France is well known to us," said Michael A. McManus, Jr., President and Chief Executive Officer of Misonix. "Their success in introducing state-of-the-art medical devices was appealing to Misonix and we are excited that they will be selling BoneScalpel through their extensive neuro-spine distribution network."
About Misonix:Misonix, Inc. designs, develops, manufactures
and markets therapeutic ultrasonic medical devices and laboratory
equipment. Misonix's therapeutic ultrasonic platform is the
basis for several innovative medical technologies. Addressing
a combined market estimated to be in excess of $3 billion annually;
Misonix's proprietary ultrasonic '/>"/>